NCT03084744 is a NA clinical trial of Schema therapy in Chronic Depressive Disorder, sponsored by Institute for Health Economics and Policy, Japan.

Who is sponsoring NCT03084744?

NCT03084744 is sponsored by Institute for Health Economics and Policy, Japan.

What drugs are being tested in NCT03084744?

Interventions in NCT03084744: Schema therapy, Active monitoring.

What condition does NCT03084744 study?

NCT03084744 studies Chronic Depressive Disorder, Dysthymic Disorder.

Is NCT03084744 still recruiting?

NCT03084744 is currently status unknown. Last updated 8 March 2018.

Last reviewed 2018-03-08 · How we verify

NCT03084744

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Schema Therapy for Chronic Depression

Status unknown NA Last updated 8 March 2018

What this trial tests

NA trial testing Schema therapy in Chronic Depressive Disorder in 64 participants. Status unknown.

Timeline

21 August 2017

Primary endpoint
1 May 2025

1 May 2025

Quick facts

Lead sponsor	Institute for Health Economics and Policy, Japan
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	64
Start date	21 August 2017
Primary completion	1 May 2025
Estimated completion	1 May 2025
Sites	1 location across Japan

Drugs / interventions tested

Schema therapy
Active monitoring

Conditions studied

Chronic Depressive Disorder — all drugs for Chronic Depressive Disorder →
Dysthymic Disorder — all drugs for Dysthymic Disorder →

Sponsor

Institute for Health Economics and Policy, Japan

Who can join

Adults 40 to 65, female only, with Chronic Depressive Disorder or Dysthymic Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare the efficacy of schema therapy versus active monitoring for women with chronic depression receiving psychiatric care.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Schema therapy

Trials testing the same drug.

NCT06655623 — A Multiple Case Study of Schema Therapy for Difficult-to-treat Depression- DEPRE-ST*Case · NA · completed
NCT05833087 — Schema Therapy for Patients With Chronic Treatment Resistant Depression · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03084744 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Institute for Health Economics and Policy, Japan
Last refreshed: 8 March 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03084744.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing